NCT06118463 is a clinical trial of Detection of serum AUNIP expression in Cervical Cancer, sponsored by Lin Yuan.

Who is sponsoring NCT06118463?

NCT06118463 is sponsored by Lin Yuan.

What drugs are being tested in NCT06118463?

Interventions in NCT06118463: Detection of serum AUNIP expression.

What condition does NCT06118463 study?

NCT06118463 studies Cervical Cancer.

Is NCT06118463 still recruiting?

NCT06118463 is currently not yet recruiting. Last updated 9 November 2023.

Last reviewed 2023-11-09 · How we verify

NCT06118463

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on AUNIP as a Novel Tumor Marker for Cervical Cancer

Not yet recruiting Last updated 9 November 2023

What this trial tests

trial testing Detection of serum AUNIP expression in Cervical Cancer in 300 participants. Not yet recruiting.

Timeline

1 January 2024

Primary endpoint
1 October 2027

1 January 2029

Quick facts

Lead sponsor	Lin Yuan
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 January 2024
Primary completion	1 October 2027
Estimated completion	1 January 2029

Drugs / interventions tested

Detection of serum AUNIP expression

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Lin Yuan — full company profile →

Who can join

Adults 20 to 60, female only, with Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Lin Yuan trials

Trials by the same sponsor.

NCT06055114 — Study on Vaginal Microecology and Cervical Local Immune Function in Patients With Uterine Fibroids of Childbearing Age · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06118463 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lin Yuan
Last refreshed: 9 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06118463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing